Pre-existing hypercoagulability in patients undergoing potentially curative cancer resection

Surgery (United States)

Volumn 155, Issue 1, 2014, Pages 134-144

  Thorson, Chad M ^a   Van Haren, Robert M ^a   Ryan, Mark L ^a   Curia, Emiliano ^a   Sleeman, Danny ^a   Levi, Joe U ^a   Livingstone, Alan S ^a   Proctor, Kenneth G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BILE DUCT CANCER; BLOOD CLOTTING; BLOOD SAMPLING; CANCER STAGING; CANCER SURGERY; CONFERENCE PAPER; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPERCOAGULABILITY; INFORMED CONSENT; LAPAROTOMY; LIVER CANCER; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEOPLASM; PANCREAS CANCER; PERINEURAL INVASION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; ROTATIONAL THROMBOELASTOMETRY; STOMACH CANCER; THROMBOELASTOGRAPH; THROMBOELASTOGRAPHY; TUMOR LOCALIZATION; ARTICLE; DIGESTIVE SYSTEM TUMOR; THROMBOPHILIA; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; FLORIDA; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THROMBOPHILIA;

EID: 84896457457     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2013.06.053     Document Type: Conference Paper

References (48)

1. The Surgeon General's call to action to prevent deep venous thrombosis and pulmonary embolism. Washington, DC: US Department of Health and Human Services; 2008.
2. Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med 2010;38(4 Suppl):S495-501.
3. Trousseau A. Phlegmasia alba dolens. Paris: Bailliere JB et Fils; 1877.
4. Varki A. Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood 2007; 110: 1723-9.
5. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160: 809-15.
6. Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med 2006; 119: 60-8.
7. Dipasco PJ, Misra S, Koniaris LG, Moffat FL Jr. Thrombophilic state in cancer, part I: biology, incidence, and risk factors. J Surg Oncol 2011; 104: 316-22.
8. Kessler CM. The link between cancer and venous thromboembolism: a review. Am J Clin Oncol 2009;32(4 Suppl):S3-7.
9. Thompson CM, Rodgers LR. Analysis of the autopsy records of 157 cases of carcinoma of the pancreas with particular reference to the incidence of thromboembolism. Am J Med Sci 1952; 223: 469-78.
10. Bagot CN, Arya R. Virchow and his triad: a question of attribution. Br J Haematol 2008; 143: 180-90.
11. Hartert H. Blutgerninnungstudien mit der thrombelastographic Einen Neven Untersuchingsver Fahren. Klin Wochenschr 1948; 26: 577-83.
12. Cotton BA, Faz G, Hatch QM, et al. Rapid thrombelastography delivers real-time results that predict transfusion within 1 hour of admission. J Trauma 2011; 71: 407-14.
13. Johansson PI. Coagulation monitoring of the bleeding traumatized patient. Curr Opin Anaesthesiol 2012; 25: 235-41.
14. Wang SC, Shieh JF, Chang KY, et al. Thromboelastographyguided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplant Proc 2010; 42: 2590-3.
15. Schreiber MA, Differding J, Thorborg P, Mayberry JC, Mullins RJ. Hypercoagulability is most prevalent early after injury and in female patients. J Trauma 2005; 58: 475-80.
16. Burke GW 3rd, Ciancio G, Figueiro J, et al. Hypercoagulable state associated with kidney-pancreas transplantation. Thromboelastogram-directed anti-coagulation and implications for future therapy. Clin Transplant 2004; 18: 423-8.
17. Dai Y, Lee A, Critchley LA, White PF. Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature. Anesth Analg 2009; 108: 734-42.
18. De Pietri L, Montalti R, Begliomini B, et al. Thromboelastographic changes in liver and pancreatic cancer surgery: hypercoagulability, hypocoagulability or normocoagulability? Eur J Anaesthesiol 2010; 27: 608-16.
19. Francis JL, Francis DA, Gunathilagan GJ. Assessment of hypercoagulability in patients with cancer using the Sonoclot Analyzer and thromboelastography. Thrombos Res 1994; 74: 335-46.
20. Wehrum MJ, Hines JF, Hayes EB, Kost ER, Hall KL, Paidas MJ. Comparative assessment of hypercoagulability in women with and without gynecologic malignancies using the thromboelastograph coagulation analyzer. Blood Coagul Fibrinolysis 2010; 21: 140-3.
21. Zuckerman L, Cohen E, Vagher JP, Woodward E, Caprini JA. Comparison of thrombelastography with common coagulation tests. Thromb Haemost 1981; 46: 752-6.
22. Thorson CM, Van Haren RM, Ryan ML, et al. Persistence of hypercoagulable state after resection of intra-abdominal malignancies. J Am Coll Surg 2013; 216: 580-9.
23. Lang T, Bauters A, Braun SL, et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005; 16: 301-10.
24. Viuff D, Andersen S, Sorensen BB, Lethagen S. Optimizing thrombelastography (TEG) assay conditions to monitor rFVIIa (NovoSeven) therapy in haemophilia A patients. Thrombosis Res 2010; 126: 144-9.
25. McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, Bennett- Guerrero E. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005; 100: 1576-83.
26. Wilson D, Cooke EA, McNally MA, Wilson HK, Yeates A, Mollan RA. Changes in coagulability as measured by thrombelastography following surgery for proximal femoral fracture. Injury 2001; 32: 765-70.
27. Caprini JA, Zuckerman L, Cohen E, Vagher JP, Lipp V. The identification of accelerated coagulability. Thrombosis Res 1976; 9: 167-80.
28. Haid M. Thromboelastographic distinction of malignant from benign breast masses: a preliminary report. South Med J 1977; 70: 774-6.
29. Roullet S, Pillot J, Freyburger G, et al. Rotation thromboelastometry detects thrombocytopenia and hypofibrinogenaemia during orthotopic liver transplantation. Br J Anaesth 2010; 104: 422-8.
30. Stancheva A, Spassov L, Tzatchev K. Correlation between rotation thrombelastometry ROTEM analysis and standard haemostatic parameters during liver transplantation. Clin Lab 2011; 57: 407-13.
31. Ogawa S, Szlam F, Chen EP, et al. A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery. Transfusion 2012; 52: 14-22.
32. Leemann H, Lustenberger T, Talving P, et al. The role of rotation thromboelastometry in early prediction of massive transfusion. J Trauma 2010; 69: 1403-8.
33. Schochl H, Cotton B, Inaba K, et al. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care 2011; 15:R265.
34. Papa ML, Capasso F, Pudore L, et al. Thromboelastographic profiles as a tool for thrombotic risk in digestive tract cancer. Exp Oncol 2007; 29: 111-5.
35. Akay OM, Ustuner Z, Canturk Z, Mutlu FS, Gulbas Z. Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography. Med Oncol 2009; 26: 358-64.
36. Goldenberg N, Kahn SR, Solymoss S. Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism. J Clin Oncol 2003; 21: 4194-9.
37. Rickles FR, Falanga A. Molecular basis for the relationship between thrombosis and cancer. Thrombosis Res 2001; 102:V215-24.
38. Edwards RL, Rickles FR, Moritz TE, et al. Abnormalities of blood coagulation tests in patients with cancer. Am J Clin Pathol 1987; 88: 596-602.
39. Fernandez PM, Rickles FR. Tissue factor and angiogenesis in cancer. Curr Opin Hematol 2002; 9: 401-6.
40. Rickles FR, Patierno S, Fernandez PM. Tissue factor, thrombin, and cancer. Chest 2003;124(3 Suppl): 58S-68S. (Pubitemid 37128437)
41. Gordon SG, Franks JJ, Lewis B. Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thrombosis Res 1975; 6: 127-37.
42. Delluc A, Rousseau A, Delluc C, et al. Venous thromboembolism in patients with pancreatic cancer: implications of circulating tissue factor. Blood Coagul Fibrinolysis 2011; 22: 295-300.
43. Manly DA, Wang J, Glover SL, et al. Increased microparticle tissue factor activity in cancer patients with venous thromboembolism. Thrombosis Res 2010; 125: 511-2.
44. Spiezia L, Marchioro P, Radu C, et al. Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis. Blood Coagul Fibrinolysis 2008; 19: 355-60.
45. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl): 381S-453S. (Pubitemid 351894916)
46. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl): 7S-47S.
47. Mandala M, Ferretti G, Cremonesi M, Cazzaniga M, Curigliano G, Barni S. Venous thromboembolism and cancer: new issues for an old topic. Crit Rev Oncol Hematol 2003; 48: 65-80.
48. Bergqvist D. Risk of venous thromboembolism in patients undergoing cancer surgery and options for thromboprophylaxis. J Surg Oncol 2007; 95: 167-74.